Alpha-methyldopa as an adjunct to levodopa treatment of Parkinson's disease
Sweet, R.D.; Lee, J.E.; McDowell, F.
Transactions of the American Neurological Association 96: 59-65
1971
ISSN/ISBN: 0065-9479 PMID: 5159130 Document Number: 33383
Document emailed within 1 workday
Related Documents
Glasgow, G.L.; Henley, J.W.; Willoughby, E.W. 1974: L-alpha-methyldopa hydrazine (Carbidopa) combined with L-dopa in the treatment of Parkinson's disease Australian and New Zealand Journal of Medicine 4(4): 373-378Białecka, M.; Adamiak, U.; Gawrońska-Szklarz, B. 2009: Optimisation of treatment of Parkinson's disease with levodopa Neurologia i Neurochirurgia Polska 43(5): 446-459
Larsen, J.P.; Nessler, E.G.; Hestnes, A.; Vilming, S.; Holmsen, R.; Aksnes, V.; Johnson, S.; Brodtkorb, E.; Hunstad, N.A.; Helle, J.R. 1991: Treatment of Parkinson disease with levodopa depot preparations Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 111(26): 3163-3166
Stern, P.H.; McDowell, F.; Miller, J.M.; Robinson, M. 1970: Levodopa and physical therapy in treatment of patients with Parkinson's disease Archives of Physical Medicine and Rehabilitation 51(5): 273-277
Molina, J.A.; Jiménez-Jiménez, F.J.; Ortí-Pareja, M. 1999: Motor and mental complications in the long-term treatment of complicated Parkinson's disease with levodopa Revista de Neurologia 28(10): 982-990
Goulley, F.; Wolmark, Y.; Bourdeix, I.; Chaumet-Riffaud, P.D. 1993: Parlodel in early combination with levodopa in the treatment of Parkinson disease. Comparison of 2 dosage forms Therapie 48(3): 233-238
Sage, J.I.; Trooskin, S.; Sonsalla, P.K.; Heikkila, R.E. 1989: Experience with continuous enteral levodopa infusions in the treatment of 9 patients with advanced Parkinson's disease Neurology 39(11 Suppl 2: 60
Timofeeva, A.A. 2014: Treatment for advanced Parkinson's disease with intestinal levodopa/carbidopa gel: review of efficacy and safety Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(11): 145-151
Fernandez-Pajarin, G.; Ares-Pensado, B.; Sesar, A.; Iglesias-Canle, J.; Masa-Vazquez, L.; Castro, A. 2018: Outpatient establishment and initial management of treatment with intraduodenal levodopa-carbidopa infusion in advanced Parkinson's disease Revista de Neurologia 67(1): 1-5
Olanow, C.W.; Alberts, M.J. 1987: Double-blind controlled study of pergolide mesylate as an adjunct to Sinemet in the treatment of Parkinson's disease Advances in Neurology 45: 555-560
Fiszer, U. 1989: Study of the immunologic status of persons with Parkinson disease with special reference to the effect of levodopa treatment. Preliminary report Neurologia i Neurochirurgia Polska 23(1): 7-11
Arai, M. 2012: Levodopa in combination with carbidopa does not affect plasma arginine vasopressin levels in treatment-naïve older patients with Parkinson's disease: a before-after study Neuro Endocrinology Letters 33(1): 34-36
Aaltonen, H.; Kilkku, O.; Heinonen, E.; Mäki-Ikola, O. 1998: Effect of adding selegiline to levodopa in early, mild Parkinson's disease. Evidence is insufficient to show that combined treatment increases mortality Bmj 317(7172): 1586-1587
Lökk, J. 2003: Treatment with levodopa can affect latent vitamin B 12 and folic acid deficiency. Patients with Parkinson disease runt the risk of elevated homocysteine levels Lakartidningen 100(35): 2674-2677
Vajda, F.J.; Donnan, G.A.; Bladin, P.F. 1978: Patterns of response to levodopa in Parkinson's disease Clinical and Experimental Neurology 15: 299-306
Muenter, M.D.; Sharpless, N.S.; Tyce, G.M. 1972: Plasma 3-0-methyldopa in L-dopa therapy of Parkinson's disease Mayo Clinic Proceedings 47(6): 389-395
Slaoui, T.; Mas-Gerdelat, A.; Ory-Magne, F.; Rascol, O.; Brefel-Courbon, C. 2007: Levodopa modifies pain thresholds in Parkinson's disease patients Revue Neurologique (Paris) 163(1): 66-71
Lee, S.T.; Lu, C.S. 1996: Ventrolateral thalamotomy for dyskinesia following levodopa therapy of Parkinson's disease Journal of the Formosan Medical Association 95(12): 943-945
Houeto, J.L.; Mesnage, V.; Welter, M.L.; Mallet, L.; Agid, Y.; Bejjani, B.P. 2003: Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up Neurology 60(1): 154-5; Author Reply 154-5
Rudakova, A.V.; Yakupov, E.Z. 2014: Pharmacoeconomic aspects of using levodopa/carbidopa intestinal gel in Parkinson's disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(10): 117-121